BRIAN CORMIER: Open Payments
NPI 1407045586 · ESCALON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 35 payments from 9 companies in 2025. Trend: 2023 $247 · 2024 $538 · 2025 $528
Food & beverage: $483Education: $45
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $153 |
| PFIZER INC. | 12 | $135 |
| Lilly USA, LLC | 3 | $76 |
| Amgen Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Novo Nordisk Inc | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, NURTEC ODT, ZAVZPRET, OTEZLA, JARDIANCE, MOUNJARO, ARISTADA, SHINGRIX.
Industry payments across CA — which companies pay providers there.
